Oncternal Therapeutics
0 followers
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer progression.
Org chart
James Breitmeyer
President & CEO
James Breitmeyer
Collapse
Salim Yazji
Chief Medical Officer
Chase Leavitt
General Counsel
Pablo Urbaneja
SVP, Corporate Development
Anita Wiseth
SVP, Human Resources
Angela Pietrofeso
VP, Clinical Development Operations
Mary Breitmeyer
Vp, Technical Operations & Alliance Management
Teams
View all
